PYC Therapeutics Limited
PYCXF
$0.8462
$0.178626.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -122.56% | -92.98% | -61.62% | -23.42% | 12.07% |
| Total Depreciation and Amortization | 33.57% | 26.06% | 18.11% | 0.22% | -16.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -93.36% | -96.26% | 63.77% | -40.84% | -44.82% |
| Change in Net Operating Assets | 11.81% | 11.81% | 11.81% | 67.96% | 79.41% |
| Cash from Operations | -148.36% | -97.18% | -54.27% | -10.29% | 28.72% |
| Capital Expenditure | -23.44% | 3.27% | 39.35% | -0.29% | -48.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | -23.44% | 2.06% | 37.58% | -104.06% | -102.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.38% | -25.88% | -26.46% | -37.13% | -51.31% |
| Issuance of Common Stock | 148.44% | 290.43% | 627.73% | 865.28% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.70% | -60.70% | -60.70% | -160.70% | -- |
| Cash from Financing | 151.03% | 299.25% | 666.82% | 915.88% | 15,881.06% |
| Foreign Exchange rate Adjustments | 234.70% | 216.04% | 108.20% | -979.29% | -1,199.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.24% | 1,503.41% | 471.05% | 432.21% | 305.11% |